Is This New Rheumatoid Arthritis Treatment a Game Changer?
Antares Pharma just patented a self-injectable version of a widely available generic drug. Can this new treatment decrease the company’s dependence on its larger generic customers?
Will Antares' FDA Decision Mean Good News for Arthritis Patients?
AbbVie probably isn't quaking in its boots with the FDA's decision to approve Antares' Otrexup. However, this could be great news for arthritis and psoriasis patients.